Kopran Ltd is an integrated Pharmaceutical Company committed to manufacturing and supplying International Quality Formulations and Active Pharmaceutical Ingredients worldwide. Founded in 1958, Kopran prides itself on its manufacturing facilities and products with accreditations in all continents. The company's Research & Development efforts to develop new products and processes for both Formulations & Active Pharmaceutical Ingredients are at the core of Kopran's growth strategy. With its headquarters in India, Kopran Ltd. spans across the Biotechnology, Health Care, Manufacturing, and Pharmaceutical industries. As a Venture Capital firm, it is crucial to monitor the diverse and extensive operations of Kopran Ltd. Given its global presence and commitment to quality manufacturing, Kopran presents an attractive investment opportunity. The company's long-standing presence in the pharmaceutical industry, coupled with its emphasis on research & development, positions it as a potential leader in the global market. With the increasing demand for high-quality pharmaceutical products worldwide, Kopran's capabilities and accreditations make it a promising prospect for potential investment consideration.
There is no investment information
No recent news or press coverage available for Kopran Ltd.